The UT Southwestern Office for Technology Development protects, enhances and advances UT Southwestern innovations to maximize benefits for community health. It advances research discoveries into commercial technologies, cultivates partnerships with faculty and external partners, and supports both licensing and new company formation. The office is based at Pegasus Park, a Dallas biotech campus, and works alongside UT Southwestern's Innovation Hub. It publishes cumulative metrics on disclosures, patents, licenses, startups and license revenue.
Documented successes: 2,248 inventions disclosed; 509 U.S. patents issued; 944 licenses and options executed; 94 startups formed; $204,918,551 in license revenue and $231,956,902 in sponsored research since FY12; spinouts include Taysha Gene Therapeutics, ReCode Therapeutics, OncoNano Medicine, Peloton Therapeutics, Exonics Therapeutics and Rodeo Therapeutics